Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1993
11/25/1993CA2135201A1 Universal coronavirus vaccine
11/25/1993CA2134898A1 Compositions and methods for vaccination against coronaviruses
11/25/1993CA2134200A1 New tricyclic thiazolo and thiazino derivatives and pharmaceutical agents containing them
11/25/1993CA2133583A1 Antiviral peptides
11/25/1993CA2113437A1 Fusion protein from feline leukaemia virus gp70 as vaccine
11/24/1993EP0570682A1 Synthetic lipid A glycoconjugate antigens for use in vaccines
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993EP0570514A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom
11/24/1993EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods
11/24/1993EP0470995B1 Use of steroidal compounds as anti-fungal agents
11/24/1993CN1022801C Process for the preparation of canine parvovirus vaccines
11/23/1993US5264621 Decanediylbis(carbonylamino)bis(1,5-naphthalenedisulfonic acid for AIDS treatment
11/23/1993US5264619 Anti-androgenic cyclo and bicyclo alkenes
11/23/1993US5264618 For transport of biological active agents into cells for viral agents or polynucleotides or immunogenic peptides
11/23/1993US5264417 Dosing an effective amount of bicozamycin ester derivatives
11/23/1993US5264216 Treatment of bacterial infections
11/23/1993US5264206 Nail lacquer with antimycotic activity, and a process for the preparation thereof
11/18/1993EP0570357A2 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates
11/18/1993EP0569811A1 Dithiolanylglycine containing HIV-protease inhibitors of the hydroxyethylene isostere type
11/18/1993EP0569703A2 Method of treating and preventing viral infections using HBNF and MK protein
11/18/1993EP0569575A1 Trisubstituted pyrrole derivatives having antifungine activity, a process for their preparation and related pharmaceutical compositions
11/18/1993EP0569564A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
11/18/1993EP0569533A1 Aryl macrocyclic compositions for treating viral infections
11/18/1993EP0569476A1 Repressors of the trans-activating function of papillomavirus e2 proteins
11/18/1993EP0569457A1 Use of thiazolo- 2,3-a]isoindole derivatives as antiviral medicaments and novel thiazolo- 2,3-a]isoindole derivatives.
11/18/1993EP0465481B1 New substituted alkylamide derivatives of teicoplanin
11/17/1993CN1078473A "Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof"
11/16/1993US5262439 Soluble analogs of probucol
11/16/1993US5262423 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993US5262173 Pulsatile once-a-day delivery systems for minocycline
11/16/1993US5262150 Antifungus composition in dry spray form
11/16/1993CA1324332C Empty viral capsid vaccines
11/15/1993CA2095968A1 Dithiolanylglycine-containing hiv protease inhibitors of the hydroxyethylene isostere type
11/11/1993WO1993023405A1 Use of tricyclic pyrimidine derivatives as anti-viral medicaments
11/11/1993WO1993022449A1 Inhibitory factor
11/11/1993WO1993022341A1 Synthetic peptide vaccines for dental caries
11/11/1993WO1993022338A1 Peptides of human papilloma virus for use in human t cell response inducing compositions
11/11/1993WO1993022292A1 New quinazolines as inhibitors of hiv reverse transcriptase
11/11/1993WO1993022288A1 Pleuromutilin derivatives
11/11/1993WO1993022262A1 Novel bis-phenyl-hexenes
11/11/1993WO1993021992A1 Laser treatment
11/11/1993WO1993021950A1 Vaccine compositions for mucosal delivery
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021943A1 Antiviral agent comprising cd4 and an h2 histone
11/11/1993WO1993021941A1 Treatment of herpesvirus infection
11/11/1993WO1993021940A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993WO1993021934A1 Heteropolytungstates in the treatment of flavivirus infections
11/11/1993WO1993021923A1 Stable hydrated cephalosporin dry powder for oral suspension formulation
11/11/1993WO1993021914A1 Soluble analogs of probucol
11/11/1993WO1993021901A1 Galenic form for ocular administration and process for the preparation of same
11/11/1993WO1993021769A1 Diphtheria toxin receptor-binding region
11/11/1993WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides
11/11/1993DE4214830A1 Neue Tricyclische Thiazolo- und Thiazino-Derivate und diese enthaltende Arzneimittel New Tricyclic thiazolo- and thiazino derivatives and pharmaceutical compositions containing them
11/11/1993DE4214829A1 Verwendung von tricyclischen Pyrimidin-Derivaten als antivirale Arzneimittel Use of tricyclic pyrimidine derivatives as antiviral drugs
11/11/1993CA2135052A1 Diphtheria toxin receptor-binding region
11/11/1993CA2134877A1 Heteropolytungstates in the treatment of flavivirus infection
11/11/1993CA2134467A1 Stable hydrated cephalosporin dry powder for oral suspension formulation
11/11/1993CA2134443A1 Inhibitory factor
11/11/1993CA2134218A1 Tricyclic pyrimidine derivatives as antiviral therapeutic agents
11/11/1993CA2134119A1 Treatment of herpesvirus infection
11/11/1993CA2133580A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
11/11/1993CA2112798A1 Peptides of human papilloma virus for use in human t cell response inducing compositions
11/10/1993EP0569083A1 New quinazolines as inhibitors of HIV reverse transcriptase
11/10/1993EP0568726A2 Stabilized varicella live vaccine
11/10/1993EP0568539A1 Soluble mannose receptor peptides
11/10/1993CN1022687C Process for prepn. of glycoside derivatives
11/09/1993US5260341 Product and process for treating bovine mastitis and bovine metritis
11/09/1993US5260279 Enteral nutrition and medical foods having soluble fiber
11/09/1993CA1324155C Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/09/1993CA1324144C Process for the preparation of new imidazole derivatives, and the use thereof as pharmaceutical agents
11/09/1993CA1324141C 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]- quinoline-carboxylic acids
11/09/1993CA1324076C Swine dysentery vaccine
11/08/1993CA2095588A1 Synthetic lipid a glycoconjugate antigens for use in vaccines
11/08/1993CA2095194A1 Quinazolines as inhibitors of hiv reverse transcriptase
11/03/1993EP0568200A2 Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0568001A2 Antiviral agent containing crude drug
11/03/1993EP0567982A1 Azole compounds, their production and use
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567559A1 Anti-hiv activity of liposomal nystatin and amphotericin b
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0469064B1 Use of c-20 to c-26 aliphatic alcohols for the manufacture of a medicament for the treatment of viral infections
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993CN1077960A Hemoregulatory peptides
11/03/1993CN1077957A Antibiotic compounds
11/03/1993CN1077886A The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4) benzoxazine-6-carboxylic acids and esters as medicaments
11/02/1993US5258518 Antiviral agents, anti-HIV activity
11/02/1993CA1323877C Triazole derivatives for use as antimycotic agents
10/1993
10/29/1993CA2094962A1 Azole compounds, their production and use
10/28/1993WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993WO1993021310A1 Attenuated respiratory syncytial virus vaccine compositions
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021207A1 Process for making vancomycin
10/28/1993WO1993021187A1 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME
10/28/1993WO1993021186A1 Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
10/28/1993WO1993021184A1 Biphenylylquinuclidine derivatives as squalene synthase inhibitors
10/28/1993WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
1 ... 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 ... 1798